Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 79,741 | 81,675 | 69,615 | 64,849 | 56,538 |
| Gross Profit | 79,741 | 81,675 | 69,615 | 64,849 | 56,538 |
| Operating Expenses | 38,092 | 41,503 | 33,742 | 33,121 | 33,174 |
| Operating Income | 41,649 | 40,172 | 35,873 | 31,728 | 23,364 |
| Other Income | 4,002 | 5,510 | 6,977 | 8,257 | 9,723 |
| Pre-tax Income | 45,651 | 45,682 | 42,850 | 39,985 | 33,087 |
| Income Tax | 15,978 | 16,940 | 15,893 | 14,832 | 12,280 |
| Net Income Continuous | 29,673 | 28,742 | 26,957 | 25,153 | 20,807 |
| Net Income | $29,673 | $28,742 | $26,957 | $25,153 | $20,807 |
| EPS Basic Total Ops | 0.19 | 0.18 | 0.18 | 0.17 | 0.14 |
| EPS Basic Continuous Ops | 0.19 | 0.19 | 0.18 | 0.17 | 0.14 |
| EPS Diluted Total Ops | 0.17 | 0.16 | 0.16 | 0.15 | 0.12 |
| EPS Diluted Continuous Ops | 0.16 | 0.12 | 0.16 | 0.15 | 0.12 |
| EBITDA(a) | $43,541 | $42,041 | $37,487 | $33,197 | $24,718 |